LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Feb 28, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 26.80%-809.11K | 12.09%-1.15M | -33.31%-5.06M | 91.70%-172K | 51.68%-1.11M | 35.40%-1.31M | 53.82%-3.79M | -30.37%-8.21M | -20.72%-1.83M | -36.31%-2.07M |
Net income from continuing operations | -17.23%-1.53M | -13.47%-1.99M | -32.25%-6.66M | 61.97%-871.66K | 41.79%-1.31M | 20.64%-1.75M | 42.09%-5.03M | -17.71%-8.69M | 18.85%-1.95M | 7.98%-2.29M |
Operating gains losses | ---- | ---- | --1.42M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | 344.41%95.41K | 922.46%287.59K | 104.16%1.47M | -8.58%24.55K | -28.10%21.47K | -10.95%28.13K | 519.29%719.41K | 23.44%116.17K | 58.30%27.87K | -3.00%26.86K |
Change In working capital | 1,562.72%615.16K | 192.63%532.43K | -368.47%-1.4M | 658.04%613.87K | 113.65%37K | 427.14%181.95K | 195.99%521.49K | -272.00%-543.28K | -120.25%-106.55K | -54.13%-110K |
-Change in receivables | -89.96%16.56K | -96.08%6.32K | -13,219.71%-662.94K | 82.18%-13.55K | 636.81%165K | 6.62%161.17K | -87.55%5.05K | 150.32%40.57K | -101.51%-3.85K | 72.59%-76.01K |
-Change in inventory | ---- | ---- | ---- | 189.77%164.97K | 378.75%4.37K | 109.08%6.54K | ---- | -377.63%-240.86K | -88.74%16.49K | -1,824.65%-183.77K |
-Change in prepaid assets | 18.20%115.72K | 82.53%-22.67K | -732.58%-308.67K | 314.65%99.27K | 189.65%97.9K | -154.48%-129.78K | 439.06%48.8K | 268.42%9.05K | 342.14%72.5K | -222.84%-46.25K |
-Change in payables and accrued expense | 344.60%499.01K | 383.09%534.49K | -199.66%-531.37K | 92.49%379.28K | 16.06%-204.01K | 216.23%110.64K | 264.94%533.19K | -170.33%-323.26K | -238.53%-182.07K | 26.38%197.04K |
-Change in other current liabilities | ---- | ---- | --0 | ---- | ---- | ---- | ---18.7K | ---- | ---- | ---- |
-Change in other working capital | 38.55%-16.13K | -57.21%14.28K | 319.73%102.95K | -1,486.80%-16.11K | 11.22%-26.26K | 192.18%33.37K | -62.79%-46.86K | -89.72%-28.78K | 57.63%-9.62K | -104.63%-1.02K |
Cash from discontinued investing activities | -1.13K | 8.91K | -675.31K | 0 | ||||||
Operating cash flow | 26.70%-810.24K | 12.77%-1.14M | -51.12%-5.73M | 91.70%-172K | 51.68%-1.11M | 35.40%-1.31M | 53.82%-3.79M | -30.37%-8.21M | -20.72%-1.83M | -36.31%-2.07M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -1,375.91%-220.16K | -255.22%-169.41K | 122.86%980.94K | 91.94%-4.91K | 73.81%-14.92K | 66.44%-47.69K | -1,003.17%-4.29M | -8.12%-388.96K | -22.89%-129.01K | 58.50%-60.91K |
Capital expenditure reported | ---220.16K | ---169.41K | 56.83%-1.02M | ---- | ---- | ---- | ---2.35M | ---- | ---- | ---- |
Net PPE purchase and sale | ---- | ---- | -216.02%-9.25K | --35.48K | 7,186.00%42.52K | --0 | 98.22%-2.93K | 9.81%-164.62K | -22.59%-80.77K | --0 |
Net intangibles purchase and sale | ---- | ---- | ---- | 33.68%-40.39K | -1.93%-57.43K | 18.96%-47.69K | ---- | -26.58%-224.34K | -23.41%-48.24K | 26.66%-60.91K |
Net business purchase and sale | ---- | ---- | --2.01M | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---1.93M | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -1,375.91%-220.16K | -255.22%-169.41K | 122.86%980.94K | 91.94%-4.91K | 73.81%-14.92K | 66.44%-47.69K | -1,003.17%-4.29M | -8.12%-388.96K | -22.89%-129.01K | 58.50%-60.91K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1.1M | 1.02M | -41.10%4.79M | 8.13M | 0 | 0 | ||||
Net issuance payments of debt | --40K | --100K | -79.09%735.06K | ---- | ---- | ---- | --3.51M | ---- | ---- | ---- |
Net common stock issuance | ---- | ---- | --1.91M | ---- | ---- | ---- | --0 | --0 | --0 | ---- |
Net preferred stock issuance | ---- | ---- | --1.6M | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net other financing activities | --965.73K | --924.59K | -88.16%547.28K | ---- | ---- | ---- | --4.62M | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --1.1M | --1.02M | -41.10%4.79M | --364.56K | --0 | --0 | --8.13M | --0 | --0 | --0 |
Net cash flow | ||||||||||
Beginning cash position | -97.54%36.68K | -88.62%323.81K | 22.26%282.48K | -94.69%368.44K | -83.95%1.49M | -75.14%2.85M | -97.98%231.05K | 209.31%11.45M | -63.25%4.8M | -52.93%6.93M |
Current changes in cash | 105.83%65.33K | 78.84%-287.13K | -19.63%41.33K | 108.80%187.64K | 52.22%-1.12M | 37.43%-1.36M | 100.60%51.43K | -211.04%-8.6M | -20.86%-1.95M | -27.96%-2.13M |
End cash Position | -72.31%102.01K | -97.54%36.68K | 14.63%323.81K | -88.42%556.09K | -94.69%368.44K | -83.95%1.49M | -90.07%282.48K | -75.14%2.85M | -75.14%2.85M | -63.25%4.8M |
Free cash flow | 11.38%-1.03M | 3.35%-1.31M | -9.87%-6.76M | 90.04%-212.4K | 50.40%-1.16M | 37.43%-1.36M | 28.50%-6.15M | -29.17%-8.6M | -20.86%-1.95M | -27.96%-2.13M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |